Kiniksa Pharmaceuticals International, plc KNSA Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's other non-current assets?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported other non-current assets of $11.16M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's other non-current assets changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's other non-current assets increased by 36.1% year-over-year, from $8.2M to $11.16M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's other non-current assets?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's other non-current assets has grown at a 15.1% compound annual growth rate (CAGR), from $5.59M to $11.31M.
- What does other non-current assets mean?
- This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.